Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmagenix is a UK-based life sciences company specializing in pharmacogenomics (PGx) and personalized medicine. The company provides advanced genetic testing services designed to help healthcare providers optimize drug selection and dosing based on an individual's unique genetic profile. By identifying genetic variations that influence drug metabolism and therapeutic response, Pharmagenix aims to reduce the incidence of adverse drug reactions and improve clinical outcomes across multiple therapeutic areas, including psychiatry, cardiology, and pain management. Their core offering includes comprehensive testing panels that analyze key enzymes and transporters involved in the processing of hundreds of commonly prescribed medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmagenix.